Home > Insider Trading > Filing (0001022079-18-000096)

Filing Details

Accession Number:: 0001022079-18-000096
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-12 16:33:53
Reporting Period:: 2018-03-08

Accepted Time:: 2018-03-12 16:33:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1477972	R Jon Cohen	500 Plaza Drive Secaucus NJ 07094	Svp & Group Exec. Diag. Sol.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-08	38,928	$66.51	115,426	No	4	M	Direct
Common Stock	Disposition	2018-03-08	18,037	$104.09	97,389	No	4	S	Direct
Common Stock	Disposition	2018-03-08	1,427	$104.76	95,962	No	4	S	Direct
Common Stock	Disposition	2018-03-08	18,164	$104.09	77,798	No	4	S	Direct
Common Stock	Disposition	2018-03-08	1,300	$104.77	76,498	No	4	S	Direct
Common Stock	Disposition	2018-03-08	34,168	$104.09	42,330	No	4	S	Direct
Common Stock	Disposition	2018-03-08	2,800	$104.77	39,530	No	4	S	Direct
Common Stock	Disposition	2018-03-08	7,773	$104.77	31,757	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2018-03-08	38,928	$66.51	38,928	$66.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,464		2026-02-25	No	4	M	Direct

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 7, 2018.
This transaction was executed in multiple trades at prices ranging from $103.65 to $104.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $104.66 to $104.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $103.68 to $104.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $104.70 to $104.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $103.65 to $104.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $104.70 to $104.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.